MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krumins, A. M.
Right arrow Articles by Barber, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krumins, A. M.
Right arrow Articles by Barber, R.

0026-895X/97/010144-11$3.00/0
Copyright © by The American Society for Pharmacology and Experimental Therapeutics
All rights of reproduction in any form reserved.
MOLECULAR PHARMACOLOGY 52:144-154 (1997).

The Stability of the Agonist beta 2-Adrenergic Receptor-Gs Complex: Evidence for Agonist-Specific States

Andrejs M. Krumins and Roger Barber

Department of Integrative Biology, Pharmacology, and Physiology, University of Texas-Houston Medical School, Houston, Texas 77225-0334

A restricted version of the ternary complex model for receptor-G protein complex formation has recently been proposed. Known as the two-state model, this model proposes that in the context of agonist and G protein interactions, only two thermodynamic states exist for the receptor: active (R*) and inactive (R). One form of this model suggests that only the R* state of the receptor is capable of interacting with and subsequently activating G proteins. We directly tested the kinetic aspects of a strict two-state receptor model in a cell line containing the native beta 2-adrenergic receptor that is capable of inducing Gs expression. We examined adenylyl cyclase activity in the presence of limiting GTP levels and concluded that there exists a different rate of heterotrimer dissociation (i.e., HR*G yields HR* + G*) for different beta 2-agonists. This finding is inconsistent with a strict two-state model in which R* is a characteristic of the receptor that is independent of the identity of the agonist. It implies that agonist activation of adenylyl cyclase is more complicated than a simple two-state model.


Copyright © by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. H. Moore, E. E. Millman, V. Godines, N. A. Hanania, T. M. Tran, H. Peng, B. F. Dickey, B. J. Knoll, and R. B. Clark
Salmeterol Stimulation Dissociates beta2-Adrenergic Receptor Phosphorylation and Internalization
Am. J. Respir. Cell Mol. Biol., February 1, 2007; 36(2): 254 - 261.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
D. M. Perez and S. S. Karnik
Multiple Signaling States of G-Protein-Coupled Receptors
Pharmacol. Rev., June 1, 2005; 57(2): 147 - 161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W. P. Clarke
What's for Lunch at the Conformational Cafeteria?
Mol. Pharmacol., June 1, 2005; 67(6): 1819 - 1821.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. C. Simons, S. M. Biggs, A. Waller, T. Foutz, D. F. Cimino, Q. Guo, R. R. Neubig, W.-J. Tang, E. R. Prossnitz, and L. A. Sklar
Real-time Analysis of Ternary Complex on Particles: DIRECT EVIDENCE FOR PARTIAL AGONISM AT THE AGONIST-RECEPTOR-G PROTEIN COMPLEX ASSEMBLY STEP OF SIGNAL TRANSDUCTION
J. Biol. Chem., April 2, 2004; 279(14): 13514 - 13521.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. M. Tran, J. Friedman, E. Qunaibi, F. Baameur, R. H. Moore, and R. B. Clark
Characterization of Agonist Stimulation of cAMP-Dependent Protein Kinase and G Protein-Coupled Receptor Kinase Phosphorylation of the {beta}2-Adrenergic Receptor Using Phosphoserine-Specific Antibodies
Mol. Pharmacol., January 1, 2004; 65(1): 196 - 206.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. J. Pauwels and F. C. Colpaert
Ca2+ Responses in Chinese Hamster Ovary-K1 Cells Demonstrate an Atypical Pattern of Ligand-Induced 5-HT1A Receptor Activation
J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 608 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Traynor, M. J. Clark, and A. E. Remmers
Relationship between Rate and Extent of G Protein Activation: Comparison between Full and Partial Opioid Agonists
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 157 - 161.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. D. Port and M. R. Bristow
beta -Adrenergic Receptors, Transgenic Mice, and Pharmacological Model Systems
Mol. Pharmacol., October 1, 2001; 60(4): 629 - 631.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Seifert, K. Wenzel-Seifert, U. Gether, and B. K. Kobilka
Functional Differences between Full and Partial Agonists: Evidence for Ligand-Specific Receptor Conformations
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1218 - 1226.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
C. Watson, G. Chen, P. Irving, J. Way, W.-J. Chen, and T. Kenakin
The Use of Stimulus-Biased Assay Systems to Detect Agonist-Specific Receptor Active States: Implications for the Trafficking of Receptor Stimulus by Agonists
Mol. Pharmacol., April 13, 2001; 58(6): 1230 - 1238.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. Waelbroeck
Activation of Guanosine 5'-[{gamma}-35S]thio-triphosphate Binding through M1 Muscarinic Receptors in Transfected Chinese Hamster Ovary Cell Membranes: 2. Testing the "Two-States" Model of Receptor Activation
Mol. Pharmacol., April 1, 2001; 59(4): 886 - 893.
[Abstract] [Full Text]


Home page
FASEB J.Home page
T. KENAKIN
Inverse, protean, and ligand-selective agonism: matters of receptor conformation
FASEB J, March 1, 2001; 15(3): 598 - 611.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. L. Wiens, C. S. Nelson, and K. A. Neve
Contribution of Serine Residues to Constitutive and Agonist-Induced Signaling via the D2S Dopamine Receptor: Evidence for Multiple, Agonist-Specific Active Conformations
Mol. Pharmacol., August 1, 1998; 54(2): 435 - 444.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. A. Berg, S. Maayani, J. Goldfarb, C. Scaramellini, P. Leff, and W. P. Clarke
Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus
Mol. Pharmacol., July 1, 1998; 54(1): 94 - 104.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. Grishina and C. H. Berlot
Mutations at the Domain Interface of Gsalpha Impair Receptor-mediated Activation by Altering Receptor and Guanine Nucleotide Binding
J. Biol. Chem., June 12, 1998; 273(24): 15053 - 15060.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. January, A. Seibold, B. Whaley, R. W. Hipkin, D. Lin, A. Schonbrunn, R. Barber, and R. B. Clark
beta 2-Adrenergic Receptor Desensitization, Internalization, and Phosphorylation in Response to Full and Partial Agonists
J. Biol. Chem., September 19, 1997; 272(38): 23871 - 23879.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Ghanouni, Z. Gryczynski, J. J. Steenhuis, T. W. Lee, D. L. Farrens, J. R. Lakowicz, and B. K. Kobilka
Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the beta 2 Adrenergic Receptor
J. Biol. Chem., June 29, 2001; 276(27): 24433 - 24436.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics